“harvard-medical-school” Archives

in
Entry Author Date Location
Akouos Aims for an IPO to Advance Hearing Loss Gene Therapy to Clinic 06/08/20 Boston
Ventus Launches With $60M to Shine Light on Innate Immune System Drugs 05/06/20 Boston
Affinivax Lands $120M to Take MAPS Tech Into New Vaccine Territory 04/23/20 Boston
With Harvard Tech and $5M, PIC Therapeutics Takes Aim at Cancer 04/15/20 Boston
Gilliland to Step Down as Head of Fred Hutch in 2020 09/17/19 Seattle
Healthcare’s Future is Telemedicine & AI, But Will Everyone Benefit? 08/22/19 Boston
TScan Lands $48M for Better, Safer T-Cell Receptor Cancer Therapies 07/24/19 Boston
Verve Has Top Cardio-Geneticist, $58.5M to Aim CRISPR at Heart Attacks 05/07/19 Boston
In Boston, Paul Allen Aimed to Boost Bioscience’s “Tempo of Discovery” 10/17/18 Boston
Harvard Spinout 28-7 Launches with $65M for MicroRNA Cancer Drugs 09/06/18 Boston
New Amazon-Led Healthcare Venture Taps Surgeon, Author Gawande as CEO 06/20/18 Boston
CAMP4 Hauls in $30M to Map New Ground with Drug Discovery Tech 05/31/18 Boston
Boston Tech Watch: OM1, Tidelift, Notarize, Iboss, Elucidata & More 05/25/18 Boston
Boston Tech Watch: Teradyne, American Well, Namogoo, Sentenai & More 05/07/18 Boston
Froedtert Provides Patients with Symptom Checker from Boston Startup 03/09/18 Wisconsin
Can AI Startups Compete with Tech Giants? 12/26/17 Boston
Jnana Therapeutics Emerges with $50M to Find Cellular Protein Drugs 12/15/17 Boston
Xconomy’s Diversity Award Winners Show How to Foster an Inclusive Workforce 11/27/17 Boston
Online Portals Challenge WebMD as Patients’ Source for Health Info 09/14/17 Wisconsin
Buoy Snags $6.7M for Chatbot, as A.I. Pushes Further Into Healthcare 08/09/17 Boston
Expanding Teladoc Adds Network, Tech With $440M Best Doctors Deal 06/19/17 Texas
Frequency Nabs $32M, Will Push Hearing-Loss Drugs To Human Studies 04/11/17 Boston
Frequency, Led by MIT’s Langer, Aims to Fight Hearing Loss With Drugs 01/05/17 Boston
Harvard Spinout Qstream Grabs $15M for App to Coach Sales Reps 12/01/16 Boston
After New Data, FDA Bucks Advisory Panel, Approves Sarepta’s Duchenne Drug 09/19/16 Boston
War, Surgery, and Cancer Vaccines: Meet San Antonio’s George Peoples 08/19/16 Texas
As Pfizer Buys, Closes Bind Tx, CEO Hirsch Heads to Agios 08/16/16 Boston
Bio Roundup: Precision Med and Google, Heron, Lilly, Sarepta & More 08/12/16 National
Syros Cuts Price But Bags $50M in IPO to Fuel Cancer Drug Trials 06/29/16 Boston
See Boston’s Newest Innovators & Influencers this Wed. at INFLUX 06/20/16 Boston
Page 1 of 7 next page »